Back
NeoGenomics, Inc. Stock Predictions
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
56
NEO
NeoGenomics, Inc.
Last Price:
$11.85
Seasonality Move:
55.32%
7 Day Trial
ALL ACCESS PASS
$
7
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiNeoGenomics, Inc. Stock Forecast
-
Over the next 52 weeks, NeoGenomics, Inc. has on average historically risen by 42.7% based on the past 26 years of stock performance.
-
NeoGenomics, Inc. has risen higher in 14 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 53.85%
-
Is NeoGenomics, Inc. Stock Undervalued?The current NeoGenomics, Inc. [NEO] share price is $11.84. The Score for NEO is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
NEO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will NeoGenomics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, NeoGenomics, Inc. has on average historically risen by 42.7% based on the past 26 years of stock performance.
NeoGenomics, Inc. Stock Rating
Buy
56
NeoGenomics, Inc. (NEO)
is a Buy
Is NeoGenomics, Inc. overpriced?
-
NeoGenomics, Inc. has risen higher in 14 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 53.85%
NeoGenomics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Providers & Services
Sector:
Health Care
Type:
stock
Website:
neogenomics.com
52-Week Data
52-Week High:
19.12
52-Week Low:
4.72
Prediction Charts
Market Cap:
1.5B
Price in USD:
11.84
Volume:
2.7M
Beta:
1.23
Technical Analysis
SMA50:
10.83
SMA100:
9.11
SMA200:
8.60
52-Wk Change:
-27.8%
Stock Predictions
-
Is NeoGenomics, Inc. stock public?Yes, NeoGenomics, Inc. is a publicly traded company.
-
What is the NeoGenomics, Inc. stock quote today?The NeoGenomics, Inc. stock price is 11.84 USD today.
-
How to buy NeoGenomics, Inc. stock online?You can buy NeoGenomics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 12.07 | 12.07 | 12.20 | 11.87 |
| Dec-3 | 12.06 | 12.12 | 12.25 | 11.96 |
| Dec-4 | 12.11 | 12.17 | 12.26 | 11.94 |
| Dec-5 | 12.18 | 11.90 | 12.18 | 11.75 |
| Dec-8 | 12.00 | 11.71 | 12.07 | 11.59 |
| Dec-9 | 11.72 | 11.80 | 11.94 | 11.62 |
| Dec-10 | 11.94 | 12.01 | 12.20 | 11.64 |
| Dec-11 | 12.05 | 11.77 | 12.20 | 11.69 |
| Dec-12 | 11.85 | 11.85 | 11.96 | 11.73 |
| Dec-15 | 11.92 | 11.92 | 12.19 | 11.77 |
| Dec-16 | 11.76 | 11.67 | 11.85 | 11.52 |
| Dec-17 | 11.69 | 11.63 | 11.72 | 11.46 |
| Dec-18 | 11.75 | 11.68 | 11.89 | 11.58 |
| Dec-19 | 11.68 | 11.84 | 12.04 | 11.59 |
NeoGenomics, Inc. Earnings
NeoGenomics, Inc. Earnings Report: Per Share NeoGenomics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
NeoGenomics, Inc. Forecast Revenue Growth
NeoGenomics, Inc. Stock Analysis: Historical quarterly revenues per share for NeoGenomics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.08 per share.
* NeoGenomics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.